Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, LENZ Therapeutics Inc (NASDAQ: LENZ) closed at $16.12 down -2.42% from its previous closing price of $16.52. In other words, the price has decreased by -$2.42 from its previous closing price. On the day, 0.78 million shares were traded. LENZ stock price reached its highest trading level at $16.68 during the session, while it also had its lowest trading level at $16.03.
Ratios:
For a deeper understanding of LENZ Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.63 and its Current Ratio is at 12.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 18, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $60.
On September 27, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $37.Raymond James initiated its Outperform rating on September 27, 2024, with a $37 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 17 ’25 when Olsson Shawn sold 10,000 shares for $26.10 per share. The transaction valued at 261,022 led to the insider holds 4,733 shares of the business.
SHAWN OLSSON bought 40,000 shares of LENZ for $1,024,000 on Nov 17 ’25. On Nov 07 ’25, another insider, MCCOLLUM JAMES W, who serves as the Director of the company, bought 10,500 shares for $22.79 each. As a result, the insider paid 239,278 and bolstered with 10,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 504394304 and an Enterprise Value of 303176288. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.82 while its Price-to-Book (P/B) ratio in mrq is 2.38. Its current Enterprise Value per Revenue stands at 17.324 whereas that against EBITDA is -4.479.
Stock Price History:
The Beta on a monthly basis for LENZ is 0.54, which has changed by -0.41604805 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, LENZ has reached a high of $50.40, while it has fallen to a 52-week low of $15.70. The 50-Day Moving Average of the stock is -36.97%, while the 200-Day Moving Average is calculated to be -47.77%.
Shares Statistics:
For the past three months, LENZ has traded an average of 1.21M shares per day and 1025750 over the past ten days. A total of 28.59M shares are outstanding, with a floating share count of 28.17M. Insiders hold about 9.98% of the company’s shares, while institutions hold 91.18% stake in the company. Shares short for LENZ as of 1765756800 were 7173576 with a Short Ratio of 5.93, compared to 1763078400 on 8564895. Therefore, it implies a Short% of Shares Outstanding of 7173576 and a Short% of Float of 39.48.
Earnings Estimates
LENZ Therapeutics Inc (LENZ) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.89, with high estimates of -$0.87 and low estimates of -$0.92.
Analysts are recommending an EPS of between -$2.45 and -$2.74 for the fiscal current year, implying an average EPS of -$2.64. EPS for the following year is -$2.88, with 6.0 analysts recommending between -$1.99 and -$3.65.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $3.57M. There is a high estimate of $4.3M for the next quarter, whereas the lowest estimate is $2.3M. Based on 7 analysts’ estimates, the company’s revenue will be $52.27M in the next fiscal year. The high estimate is $60.59M and the low estimate is $41.2M.
